The affected product is packaged in 18 oz. bags with expiration dates of: DEC 16 2015 SHA, DEC 17 2015 SHA, DEC 18 2015 SHA.
The expiration dates are located on the front of the bag in the upper right hand corner. No illnesses or reactions have been reported to date.
Western Milling voluntarily recalled 50 lb bags of Western Blend horse feed, LOT 5251, manufactured on September 8, 2015.
This voluntary recall was initiated by Western Milling after it learned that an ingredient in the feed in question may contain monensin, an ionophore.
According to the FDA, clinical signs of ionophore poisoning in horses vary depending on the dosage ingested, but can include poor appetite and feed refusal of the grain product, diarrhea, weakness, rapid heart rate, labored breathing, decreased exercise tolerance, depression, wobbly gait, colic, sweating, recumbency, and sudden death.
The first clinical signs are often noted from 12 to 72 hours after ingesting a toxic dose and the clinical signs may linger up to about 8 days. Permanent cardiac damage is possible in horses which showed adverse effects, but then recovered.
The feed subject to this recall was distributed in September, 2015 to stores in California and Arizona. All stores where the bags were sold have been notified. Of the 1,100 bags being recalled, all but 67 bags have already been reclaimed by the company.
Consumers are urged to examine any bags of Western Blend horse feed purchased in September, 2015 to check and see if they have Lot 5251. Any bags with this lot number may be returned to the stores where they were purchased for a full refund.
TF Supplements of Houston, Tx., is voluntarily recalling the following product to the consumer level: RHINO 7 packaged in a bottle containing six capsules WITH LOT# K824B719-P and in a single count capsule hang card with LOT# SU-5102617*RP at the consumer level.
Lot numbers are on the back top right of the count and on the side of the count bottle. FDA analysis found these products to contain undeclared desmethyl carbondenafil and dapoxetine.
Desmethyl carbondenafil is a phosphodiesterase PDE-5 inhibitor which is a class of drugs used to treat male erectile dysfunction, making these products unapproved new drugs.
Dapoxetine is an active ingredient not approved by the U.S. Food and Drug Administration (FDA). ■